MORE VIDEOS
Explore more

Sarcomas, Soft Tissue

Ct scan soft tissue sarcoma
Ct scan soft tissue sarcoma administrator 0 Views • 2 years ago

Join this channel to get access to perks:
https://www.youtube.com/channe....l/UCUbXDmSoQwQ6hga_f

Take your veterinary practice to the next level with our continuing education veterinary surgery online courses. Visit www.vetdojo.com

Hannah Morier - Sarcoma Patient
Hannah Morier - Sarcoma Patient administrator 1 Views • 2 years ago

Hannah Morier, of Albany, was about to start her senior year of college when she was diagnosed with soft tissue sarcoma – a type of cancer found in the body's connective tissues. Thanks to her orthopedic oncologist Matthew DiCaprio, M.D., and the expert, compassionate care she received at Albany Med, Hannah is now a healthy, active 23-year-old who is the 2017 Sarcoma Strong Run/Walk 5k honoree.

To register for the 2017 Run/Walk 5k, visit http://www.zippyreg.com/online...._reg/reg2017.php?e=9 or http://www.sarcomastrong.com/

Nab-paclitaxel and gemcitabine in soft tissue sarcoma: trial update
Nab-paclitaxel and gemcitabine in soft tissue sarcoma: trial update administrator 1 Views • 2 years ago

Speaking from the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain, Yannis Metaxas, MD, Cantonal Hospital Grison, Chur, Switzerland, discusses the results from the phase I part of the phase I/II SAKK 57/16 trial (NCT03524898). This study investigated nab-paclitaxel and gemcitabine in soft tissue sarcoma.
Collaboration of Experts in Soft Tissue Sarcoma
Collaboration of Experts in Soft Tissue Sarcoma administrator 2 Views • 2 years ago

Saketh Guntupalli, MD, and Victor Villalobos, MD, PhD, share how they work together to determine the best treatment approach for patients with soft tissue sarcoma.
The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma
The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma administrator 2 Views • 2 years ago

Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.
Multidisciplinary Assessment of Soft Tissue Sarcomas
Multidisciplinary Assessment of Soft Tissue Sarcomas administrator 2 Views • 2 years ago

The panelists discuss the complexity of treatment planning and the importance of multidisciplinary discussion to optimize the use of each therapeutic modality in real time.
Dr. Pautier on Remaining Challenges in Advanced Soft Tissue Sarcoma
Dr. Pautier on Remaining Challenges in Advanced Soft Tissue Sarcoma administrator 5 Views • 2 years ago

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Dr. George Discusses Ongoing Trials in Soft Tissue Sarcoma
Dr. George Discusses Ongoing Trials in Soft Tissue Sarcoma administrator 2 Views • 2 years ago

Soft Tissue Sarcoma | Dr. Talebi discusses
Soft Tissue Sarcoma | Dr. Talebi discusses administrator 1 Views • 2 years ago

Dr. Talebi discusses "What is Soft Tissue Sarcoma? With Dr. Jonathan Trent, Director of Sarcoma Program at the University of Miami. For further discussion please visit http://www.HemOnc101.com

Multidisciplinary Assessment is Critical for Soft Tissue Sarcoma
Multidisciplinary Assessment is Critical for Soft Tissue Sarcoma administrator 2 Views • 2 years ago

Expert panelists William D. Tap, MD; Jonathan C. Trent, MD, PhD; Richard F. Riedel, MD; Victor M. Villalobos, MD, PhD; and Kristen N. Ganjoo, MD, describe communication with other specialists at the multidisciplinary tumor board when planning treatment for soft tissue sarcoma in the curative setting.
Showing 17 out of 18